Abstract Guselkumab appears to be safe and effective in the treatment of patients with HS, who do not respond to adalimumab and other systemic therapies. Guselkumab can be used in patients with comorbid Crohn's disease
Hidradenitis suppurativa/acne inversa (HS) is a chronic, inflammatory, skin disease. Adalimumab is t...
Guselkumab, a subcutaneously administered fully human IgG1λ monoclonal antibody that selectively inh...
We present a case of refractory ileocolonic Crohn’s disease in a 27-year-old female treated with dua...
Herein we report the combination of adalimumab and ustekinumab to successfully treat a 39-year-old w...
Hidradenitis suppurativa (HS) is a chronic, inflammatory skin disease characterized by recurring abs...
Hidradenitis suppurativa (HS) is a chronic, inflammatory disease characterized by recurring abscesse...
A sporadic association between hidradenitis suppurativa and other diseases is reported in the litera...
Background: The treatment guidelines for hidradenitis suppurativa (HS) vary among different countrie...
Hidradenitis suppurativa is a chronic disease that affects the apocrine gland-bearing regions of the...
The introduction of TNF blockers in the therapeutic armamentarium of inflammatory bowel diseases (IB...
BACKGROUND: The effectiveness of available biologics for the treatment of hidradenitis suppurativa (...
Guselkumab, a subcutaneously administered fully human IgG1λ monoclonal antibody that selectively inh...
: To date, adalimumab (ADA) is the only biotechnology drug approved for the management of hidradenit...
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease characterized by the presence o...
Hidradenitis suppurativa/acne inversa (HS) is a chronic, inflammatory, skin disease. Adalimumab is t...
Guselkumab, a subcutaneously administered fully human IgG1λ monoclonal antibody that selectively inh...
We present a case of refractory ileocolonic Crohn’s disease in a 27-year-old female treated with dua...
Herein we report the combination of adalimumab and ustekinumab to successfully treat a 39-year-old w...
Hidradenitis suppurativa (HS) is a chronic, inflammatory skin disease characterized by recurring abs...
Hidradenitis suppurativa (HS) is a chronic, inflammatory disease characterized by recurring abscesse...
A sporadic association between hidradenitis suppurativa and other diseases is reported in the litera...
Background: The treatment guidelines for hidradenitis suppurativa (HS) vary among different countrie...
Hidradenitis suppurativa is a chronic disease that affects the apocrine gland-bearing regions of the...
The introduction of TNF blockers in the therapeutic armamentarium of inflammatory bowel diseases (IB...
BACKGROUND: The effectiveness of available biologics for the treatment of hidradenitis suppurativa (...
Guselkumab, a subcutaneously administered fully human IgG1λ monoclonal antibody that selectively inh...
: To date, adalimumab (ADA) is the only biotechnology drug approved for the management of hidradenit...
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease characterized by the presence o...
Hidradenitis suppurativa/acne inversa (HS) is a chronic, inflammatory, skin disease. Adalimumab is t...
Guselkumab, a subcutaneously administered fully human IgG1λ monoclonal antibody that selectively inh...
We present a case of refractory ileocolonic Crohn’s disease in a 27-year-old female treated with dua...
DOI
Add to ORKG